Wound Care Innovations (WCI), a subsidiary of Wound Management Technologies (WMT), has signed a distribution agreement with Healing Innovation, to facilitate the sale of CellerateRx in five Central American Countries Belize, El Salvador, Honduras, Nicaragua and Guatemala.
WMT has been focused on distribution of CellerateRx, a patented collagen product used as an advanced wound care product.
Healing Innovation has also placed its first stocking order with WCI. Ron Mathis, senior VP of marketing and sales of WCI, is in Belize coordinating the Central American product roll-out plans with Healing Innovation.
Albert Cattouse, CEO of Healing Innovation, said: “We are delighted to have been selected to represent CellerateRx here in the five countries and are anxious to be receiving the product thus helping the people in this region.”
Deborah Jenkins Hutchinson, president of Wound Management Technologies, said: “The new sales team that we put in place at Wound Care Innovations in the second quarter of 2010 has signed this critical new distributor agreement within the first ninety days on the job.
“We are all very excited about what this deal means for our company’s expansion into international markets both today and in the future.”
Cathy Bradshaw, president of Wound Care Innovations, said: “We are proud of the expanding international sales of our advanced wound care collagen product, CellerateRx, into Central America. Our team looks forward to additionally selling our products in the European Union by the end of the year.
“We are also very excited to welcome Komed, as a distribution partner here in the US who began selling our CellerateRx product as of July 1st from Texas to the Carolinas.”